IN2012DN00696A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00696A
IN2012DN00696A IN696DEN2012A IN2012DN00696A IN 2012DN00696 A IN2012DN00696 A IN 2012DN00696A IN 696DEN2012 A IN696DEN2012 A IN 696DEN2012A IN 2012DN00696 A IN2012DN00696 A IN 2012DN00696A
Authority
IN
India
Prior art keywords
iodophenylamino
dihydroxypropyl
cyclopropane
sulfonamide
difluoro
Prior art date
Application number
Other languages
English (en)
Inventor
Maderna Andreas
Vernier Jean-Michel
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00696(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of IN2012DN00696A publication Critical patent/IN2012DN00696A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IN696DEN2012 2009-07-24 2010-07-10 IN2012DN00696A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22850909P 2009-07-24 2009-07-24
US22850109P 2009-07-24 2009-07-24
PCT/EP2010/004222 WO2011009541A1 (en) 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Publications (1)

Publication Number Publication Date
IN2012DN00696A true IN2012DN00696A (es) 2015-06-19

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
IN696DEN2012 IN2012DN00696A (es) 2009-07-24 2010-07-10

Country Status (32)

Country Link
US (3) US8513443B2 (es)
EP (1) EP2462111B1 (es)
JP (1) JP5776115B2 (es)
KR (1) KR101763437B1 (es)
CN (2) CN103848808B (es)
AR (1) AR079183A1 (es)
AU (1) AU2010275780B2 (es)
BR (1) BR112012001592A2 (es)
CA (2) CA2768788C (es)
CL (1) CL2012000192A1 (es)
CO (1) CO6491075A2 (es)
CR (1) CR20120044A (es)
CU (1) CU24113B1 (es)
DO (1) DOP2012000017A (es)
EA (1) EA023623B1 (es)
EC (1) ECSP12011621A (es)
GT (1) GT201200017A (es)
HK (2) HK1171218A1 (es)
HN (1) HN2012000142A (es)
IL (1) IL217312A (es)
IN (1) IN2012DN00696A (es)
MA (1) MA33452B1 (es)
MX (2) MX2012001063A (es)
MY (1) MY160421A (es)
NZ (1) NZ597738A (es)
PE (1) PE20120573A1 (es)
PH (1) PH12014500158A1 (es)
SG (1) SG177535A1 (es)
TN (1) TN2012000027A1 (es)
TW (1) TWI524890B (es)
UY (1) UY32800A (es)
WO (1) WO2011009541A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備
PE20140580A1 (es) 2011-05-27 2014-06-01 Bayer Ip Gmbh Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas
EP2796455A4 (en) * 2011-12-19 2015-08-19 Sumitomo Chemical Co PROCESS FOR PRODUCING SULFONATE
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
CN101495118B (zh) * 2005-07-21 2012-09-05 阿迪亚生命科学公司 Mek的n-(芳基氨基)磺酰胺抑制剂
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
CA2649122C (en) 2006-04-18 2015-06-30 Ardea Biosciences, Inc. Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
EP2175885B1 (en) * 2007-07-30 2016-10-12 Ardea Biosciences, Inc. Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
EP2291350A4 (en) * 2008-04-14 2012-09-19 Ardea Biosciences Inc COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE AND USE
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備

Also Published As

Publication number Publication date
KR20120032536A (ko) 2012-04-05
CL2012000192A1 (es) 2012-10-05
EA023623B1 (ru) 2016-06-30
US8513443B2 (en) 2013-08-20
BR112012001592A2 (pt) 2016-03-08
AU2010275780A1 (en) 2012-02-02
CA2768788A1 (en) 2011-01-27
MY160421A (en) 2017-03-15
US20120178946A1 (en) 2012-07-12
DOP2012000017A (es) 2012-05-15
HN2012000142A (es) 2015-06-08
PE20120573A1 (es) 2012-05-17
KR101763437B1 (ko) 2017-07-31
AR079183A1 (es) 2012-01-04
TN2012000027A1 (en) 2013-09-19
CN102471246B (zh) 2015-08-26
TWI524890B (zh) 2016-03-11
MX2012001063A (es) 2012-03-26
EP2462111B1 (en) 2016-03-30
EP2462111A1 (en) 2012-06-13
CN102471246A (zh) 2012-05-23
IL217312A0 (en) 2012-02-29
HK1171218A1 (en) 2013-03-22
SG177535A1 (en) 2012-03-29
CU24113B1 (es) 2015-08-27
MX344965B (es) 2017-01-12
PH12014500158B1 (en) 2015-09-07
EA201200175A1 (ru) 2012-12-28
US8884058B2 (en) 2014-11-11
NZ597738A (en) 2014-03-28
ECSP12011621A (es) 2012-02-29
GT201200017A (es) 2013-12-19
WO2011009541A1 (en) 2011-01-27
AU2010275780B2 (en) 2015-10-22
CO6491075A2 (es) 2012-07-31
US20150274651A1 (en) 2015-10-01
US9296686B2 (en) 2016-03-29
UY32800A (es) 2011-01-31
CA2990097A1 (en) 2011-01-27
CR20120044A (es) 2012-03-12
MA33452B1 (fr) 2012-07-03
JP2013500242A (ja) 2013-01-07
TW201113017A (en) 2011-04-16
CN103848808B (zh) 2016-02-10
CU20120014A7 (es) 2012-06-21
CA2768788C (en) 2018-01-09
JP5776115B2 (ja) 2015-09-09
PH12014500158A1 (en) 2015-09-07
US20130261320A1 (en) 2013-10-03
IL217312A (en) 2017-02-28
CN103848808A (zh) 2014-06-11
HK1198364A1 (zh) 2015-04-10

Similar Documents

Publication Publication Date Title
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
IN2012DN06629A (es)
WO2011106322A3 (en) Biomarkers for acute ischemic stroke
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
EP2606139A4 (en) BIOCATALYSTS AND METHODS FOR SYNTHESIZING (1R, 2R) -2- (3,4-DIMETHOXYPHENYL ETHYL) CYCLOHEXANAMINE
WO2010118291A3 (en) Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
IN2012DN00696A (es)
MX2012011382A (es) Nuevo polimero.
EP2576575A4 (en) PROSTAGLANDIN-BISPHOSPHONATE CONJUGATE COMPOUNDS, THEIR METHODS OF MANUFACTURE AND USES THEREOF
WO2011054804A3 (en) Skin care compositions comprising phenoxyalkyl amines
UA106762C2 (uk) Спосіб одержання (r)- та (s)-n-(3,4-дифтор-2-(2-фтор-4-йодфеніламіно)-6-метоксифеніл)-1-(2,3-дигідроксипропіл)циклопропан-1-сульфанаміду та його захищених похідних
SG178929A1 (en) Use of cathepsin h
WO2012027274A3 (en) Compositions and methods for imaging
AU2017202012A1 (en) Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo(3.1.0)hexane in the treatment of conditions affected by monoamine neurotransmitters
UA106192C2 (en) N-(1,1-dioxotetrahydrothiophen-3-yl)bicyclo[2.2.1]hept-5-ene-endo,endo-2,3- dicarboximide and n-(1,1-dioxotetrahydrothiophen-3-yl)-exo-5,6-epoxybicyclo-[2.2.1]heptane-endo,endo-2,3-dicarboximide exhibiting analgetic and anticonvulsant action
UA91166C2 (en) use of ethyl ether N-[(2-oxoindolylinylydene-3)-2-oxyacetyl]-aminoacetic acid of the general formula as nootropic and anxyolytic agent
UA35660U (en) Use of antihomotoxic preparations as cytoprotectors
UA48043U (ru) Применение перфторана в качестве эхоконтрастного препарата при проведении интервенционных эндоваскулярных вмешательств
UA59343U (ru) Применение теобона-дитиомикоцида (n -(1,1-диоксотиолан-3-ил)-дитиокарбамата калия) как средства для лечения инфекционных поражений кожи
UA52529U (ru) Применение уретроскопа комбинированного (модель 513) как троакарной системы для эпицистостомии
UA60476U (ru) Применение (1,1-диоксотиолан-3-ил)дитиокарбамата калия в качестве антимикробного средства
UA96059C2 (ru) Применение липина как средства фригопротекторного действия